No medicine supply issues for private hospitals despite Middle East war
PETALING JAYA: Private hospitals in the country are not experiencing any disruptions in the supply of medications despite…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
Trump Touts Drug Cost Savings in TrumpRx Website Launch
President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking…
New adrenaline nasal spray a 30-year first for Australia
The first nasal spray version of adrenaline is about to arrive in Australia, costing $194 for a two-pack. Branded…
Pura Collagen enters GLP-1 market with ‘pure’ hormone stimulating alternative
The two innovations expand the startup’s product line to seven, indicating the depth of consideration that goes into…
European Obesity Stocks Join Healthcare Rally as AI Trade Ebbs
European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…
Cigna Will End Drug Rebates in Many Private Health Plans
Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, upending an…
Can Huntington’s Disease Be Cured? A New Breakthrough Gene Therapy Offers Hope
Hi, this is Naomi in Berlin. Today I’m looking west to Scotland, where the possibility of a treatment…
Pfizer to Cut Some Drug Prices in Deal With President Trump (PFE)
Pfizer Inc. Chief Executive Officer Albert Bourla said the company secured a three-year grace period from President Donald…
Stock Market Today: Dow, S&P Live Updates for September 26
Global stocks extended their slide into a fourth day as concerns over lofty valuations and mixed signals from…
Bristol to Sell 80% Off Psoriasis Pill After Trump Demand
Bristol Myers Squibb Co. will sell its pill for psoriasis directly to cash-paying patients at a more than…
US Birth Control, Indian Drugs at Risk From Trump’s 250% Tariff Threat
US President Donald Trump’s threat of imposing tariffs as high as 250%Bloomberg Terminal on pharmaceutical imports is putting…